Bristol-Myers Squibb has issued a "Dear Healthcare Provider" letter and revised labeling to inform of the potential for lactic acidosis and severe hepatomegaly with steatosis-including some fatal cases-when nucleoside analogue therapy is used alone or in combination with other antiretrovirals

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Stavudine: Lactic acidosis, motor weakness warnings

Newsletter